Inhibikase Therapeutics, Inc. (IKT)
NASDAQ: IKT · Real-Time Price · USD
2.310
+0.300 (14.93%)
At close: Nov 22, 2024, 4:00 PM
2.340
+0.030 (1.30%)
After-hours: Nov 22, 2024, 6:39 PM EST
Inhibikase Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for IKT stock have an average target of 6.50, with a low estimate of 5.00 and a high estimate of 8.00. The average target predicts an increase of 181.39% from the current stock price of 2.31.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for IKT stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 1 | 1 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Jefferies | Jefferies | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +246.32% | Nov 8, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $5 | Strong Buy | Maintains | $15 → $5 | +116.45% | Oct 14, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $23 → $15 | Strong Buy | Maintains | $23 → $15 | +549.35% | Aug 16, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $27 → $23 | Strong Buy | Maintains | $27 → $23 | +895.67% | May 21, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $27 | Strong Buy | Reiterates | $27 | +1,068.83% | Mar 7, 2024 |
Financial Forecast
Revenue This Year
n/a
from 260.50K
Revenue Next Year
n/a
EPS This Year
-0.58
from -3.57
EPS Next Year
-0.26
from -0.58
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | n/a | n/a | n/a |
Avg | n/a | n/a | n/a |
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -0.42 | -0.18 | -0.24 |
Avg | -0.58 | -0.26 | -0.26 |
Low | -0.74 | -0.33 | -0.27 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.